There has been incredible progress in the discovery and application of molecular biomarkers for multiple pathologies, including cancer and neurodegenerative diseases. Because biomarkers for precision ...

Future molecular assay platforms will have different types of biomarkers derived from multiple omics data, including genomics, proteomics, metabolomics, glycomics, lipidomics and toxicomics.

The discovery of a 'biomarker panel' could have a profound impact on the ability to identify patients at risk of developing ...

Since Henry Bence Jones first discovered a urine protein marker for multiple myeloma in 1846, the field of cancer biomarkers has grown exponentially. Over the past two centuries, scientists have ...

Analyzing this comprehensive panel of biomarkers identifies cell types that are up or downregulated in different disease states. Further, exploring the spatial relationships between cells uncovers ...